Clinical Trials Browser

Recruiting × Margins of Excision × Head & Neck × Clear all

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT07517198 2026-04-08

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07285564 2025-12-16

TEP Margins

Phase NA Recruiting

10 enrolled

Head & Neck

Margins of Excision, Head and Neck Neoplasms

NCT05933889 2024-08-07

SCORE

Recruiting

250 enrolled

Head & Neck

Margins of Excision, Head and Neck Neoplasms, Neoplasm Recurrence, Local, Oropharyngeal Neoplasms

Clinical Trials

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

TEP Margins

SCORE